☒ |
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
☐ |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
94-3125814
|
|
(State or other jurisdiction of
incorporation or organization)
|
(IRS Employer
Identification No.)
|
Title of each class
|
Trading
Symbol(s)
|
Name of each exchange
on which registered
|
||
Common Stock ($0.001 par value)
|
IVAC
|
The Nasdaq Stock Market LLC (Nasdaq) Global Select
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☒
|
|||
Non-accelerated
filer
|
☐
|
Smaller reporting company
|
☒
|
|||
Emerging growth company
|
☐
|
No.
|
Page
|
|||||
Item 1.
|
Financial Statements (unaudited) | |||||
Condensed Consolidated Balance Sheets | 3 | |||||
Condensed Consolidated Statements of Operations | 4 | |||||
Condensed Consolidated Statements of Comprehensive Income (Loss) | 5 | |||||
Condensed Consolidated Statements of Cash Flows | 6 | |||||
Notes to Condensed Consolidated Financial Statements | 7 | |||||
Item 2.
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations | 22 | ||||
Item 3.
|
Quantitative and Qualitative Disclosures About Market Risk | 30 | ||||
Item 4.
|
Controls and Procedures | 30 | ||||
Item 1.
|
Legal Proceedings | 31 | ||||
Item 1A.
|
Risk Factors | 31 | ||||
Item 2.
|
Unregistered Sales of Equity Securities and Use of Proceeds | 37 | ||||
Item 3.
|
Defaults upon Senior Securities | 37 | ||||
Item 4.
|
Mine Safety Disclosures | 37 | ||||
Item 5.
|
Other Information | 38 | ||||
Item 6.
|
Exhibits | 38 | ||||
39 |
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
|||||||||||||
(Unaudited)
|
||||||||||||||||
(In thousands, except per share amounts)
|
||||||||||||||||
Net revenues:
|
||||||||||||||||
Systems and components
|
$ | 11,700 | $ | 15,027 | $ | 35,410 | $ | 51,589 | ||||||||
Technology development
|
3,093 | 6,538 | 9,437 | 17,659 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total net revenues
|
14,793 | 21,565 | 44,847 | 69,248 | ||||||||||||
Cost of net revenues:
|
||||||||||||||||
Systems and components
|
7,120 | 8,389 | 25,708 | 29,969 | ||||||||||||
Technology development
|
2,146 | 3,876 | 7,450 | 10,403 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cost of net revenues
|
9,266 | 12,265 | 33,158 | 40,372 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Gross profit
|
5,527 | 9,300 | 11,689 | 28,876 | ||||||||||||
Operating expenses:
|
||||||||||||||||
Research and development
|
3,743 | 3,603 | 11,262 | 10,594 | ||||||||||||
Selling, general and administrative
|
5,752 | 5,845 | 17,208 | 17,426 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total operating expenses
|
9,495 | 9,448 | 28,470 | 28,020 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income (loss) from operations
|
(3,968 | ) | (148 | ) | (16,781 | ) | 856 | |||||||||
Interest income and other income (expense), net
|
25 | 8 | 75 | 212 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Income (loss) before provision for income taxes
|
(3,943 | ) | (140 | ) | (16,706 | ) | 1,068 | |||||||||
Provision for income taxes
|
290 | 217 | 157 | 1,125 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Net loss
|
$ | (4,233 | ) | $ | (357 | ) | $ | (16,863 | ) | $ | (57 | ) | ||||
|
|
|
|
|
|
|
|
|||||||||
Net loss per share:
|
||||||||||||||||
Basic and Diluted
|
$ | (0.17 | ) | $ | (0.02 | ) | $ | (0.69 | ) | $ | (0.00 | ) | ||||
Weighted average common shares outstanding:
|
||||||||||||||||
Basic and Diluted
|
24,522 | 23,771 | 24,265 | 23,605 |
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
|||||||||||||
(Unaudited)
(In thousands)
|
||||||||||||||||
Net loss
|
$ | (4,233 | ) | $ | (357 | ) | $ | (16,863 | ) | $ | (57 | ) | ||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income (loss), before tax
|
||||||||||||||||
Change in unrealized net gain on
available-for-sale
|
(7 | ) | (24 | ) | (36 | ) | 29 | |||||||||
Foreign currency translation gains (losses)
|
(7 | ) | 124 | (47 | ) | 49 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income (loss), before tax
|
(14 | ) | 100 | (83 | ) | 78 | ||||||||||
Income tax (expense) benefit related to items in other comprehensive income (loss)
|
— | — | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Other comprehensive income (loss), net of tax
|
(14 | ) | 100 | (83 | ) | 78 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Comprehensive income (loss)
|
$ | (4,247 | ) | $ | (257 | ) | $ | (16,946 | ) | $ | 21 | |||||
|
|
|
|
|
|
|
|
Nine months ended
|
||||||||
October 2,
2021
|
September 26,
2020
|
|||||||
(Unaudited)
(In thousands)
|
||||||||
Operating activities
|
||||||||
Net loss
|
$ | (16,863 | ) | $ | (57 | ) | ||
Adjustments to reconcile net loss to net cash and cash equivalents provided by (used in) operating activities:
|
||||||||
Depreciation and amortization
|
2,568 | 2,645 | ||||||
Net amortization (accretion) of investment premiums and discounts
|
88 | (9 | ) | |||||
Equity-based compensation
|
2,872 | 2,186 | ||||||
Straight-line rent adjustment and amortization of lease incentives
|
(350 | ) | (224 | ) | ||||
Deferred income taxes
|
(36 | ) | 516 | |||||
Changes in operating assets and liabilities
|
11,681 | 2,714 | ||||||
|
|
|
|
|||||
Total adjustments
|
16,823 | 7,828 | ||||||
|
|
|
|
|||||
Net cash and cash equivalents provided by (used in) operating activities
|
(40 | ) | 7,771 | |||||
Investing activities
|
||||||||
Purchases of investments
|
(13,214 | ) | (17,071 | ) | ||||
Proceeds from sales and maturities of investments
|
16,355 | 17,950 | ||||||
Purchases of leasehold improvements and equipment
|
(773 | ) | (2,329 | ) | ||||
|
|
|
|
|||||
Net cash and cash equivalents provided by (used in) investing activities
|
2,368 | (1,450 | ) | |||||
Financing activities
|
||||||||
Net proceeds from issuance of common stock
|
2,618 | 1,865 | ||||||
Common stock repurchases
|
— | (393 | ) | |||||
Taxes paid related to net share settlement
|
(545 | ) | (364 | ) | ||||
|
|
|
|
|||||
Net cash and cash equivalents provided by financing activities
|
2,073 | 1,108 | ||||||
Effect of exchange rate changes on cash
|
(47 | ) | 49 | |||||
|
|
|
|
|||||
Net increase in cash, cash equivalents and restricted cash
|
4,354 | 7,478 | ||||||
Cash, cash equivalents and restricted cash at beginning of period
|
30,128 | 20,554 | ||||||
|
|
|
|
|||||
Cash, cash equivalents and restricted cash at end of period
|
$ | 34,482 | $ | 28,032 | ||||
|
|
|
|
|||||
Non-cash
investing and financing activity
|
||||||||
Additions to
right-of-use-assets
|
$ | — | $ | 128 | ||||
|
|
|
|
1.
|
Description of Business and Basis of Presentation
|
2.
|
Revenue
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
TFE
|
Three Months Ended October 2, 2021
|
Three Months Ended September 26, 2020
|
||||||||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
HDD
|
DCP
|
PV
|
ASP
|
Total
|
HDD
|
PV
|
Total
|
|||||||||||||||||||||||||
Systems, upgrades and spare parts
|
$
|
6,495
|
|
$
|
—
|
|
$
|
61
|
|
$
|
—
|
|
$
|
6,556
|
|
$
|
7,601
|
|
$
|
131
|
|
$
|
7,732
|
|
||||||||
Field service
|
|
1,424
|
|
|
—
|
|
|
18
|
|
|
—
|
|
|
1,442
|
|
|
1,635
|
|
|
—
|
|
|
1,635
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total TFE net revenues
|
$
|
7,919
|
|
$
|
—
|
|
$
|
79
|
|
$
|
—
|
|
$
|
7,998
|
|
$
|
9,236
|
|
$
|
131
|
|
$
|
9,367
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended October 2, 2021
|
Nine Months Ended September 26, 2020
|
|||||||||||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||||||||||
HDD
|
DCP
|
PV
|
ASP
|
Total
|
HDD
|
PV
|
Total
|
|||||||||||||||||||||||||
Systems, upgrades and spare parts
|
$
|
14,034
|
|
$
|
3
|
|
$
|
219
|
|
$
|
3,850
|
|
$
|
18,106
|
|
$
|
29,189
|
|
$
|
400
|
|
$
|
29,589
|
|
||||||||
Field service
|
|
4,425
|
|
|
14
|
|
|
60
|
|
|
—
|
|
|
4,499
|
|
|
4,334
|
|
|
2
|
|
|
4,336
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Total TFE net revenues
|
$
|
18,459
|
|
$
|
17
|
|
$
|
279
|
|
$
|
3,850
|
|
$
|
22,605
|
|
$
|
33,523
|
|
$
|
402
|
|
$
|
33,925
|
|
||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
Photonics
|
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
||||||||||||
(In thousands)
|
||||||||||||||||
Products:
|
||||||||||||||||
Military products
|
$ | 3,343 | $ | 4,947 | $ | 11,552 | $ | 15,758 | ||||||||
Commercial products
|
100 | 139 | 278 | 257 | ||||||||||||
Repair and other services
|
259 | 574 | 975 | 1,649 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Photonics product net revenues
|
3,702 | 5,660 | 12,805 | 17,664 | ||||||||||||
Technology development:
|
||||||||||||||||
Firm Fixed Price (“FFP”)
|
1,571 | 5,482 | 4,919 | 15,374 | ||||||||||||
Cost Plus Fixed Fee (“CPFF”)
|
1,522 | 1,056 | 4,518 | 2,285 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total technology development net revenues
|
3,093 | 6,538 | 9,437 | 17,659 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total Photonics net revenues
|
$ | 6,795 | $ | 12,198 | $ | 22,242 | $ | 35,323 | ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||
Three Months Ended
|
Three Months Ended
|
|||||||||||||||||||||||
October 2, 2021
|
September 26, 2020
|
|||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
Photonics
|
Total
|
TFE
|
Photonics
|
Total
|
|||||||||||||||||||
United States
|
$
|
220
|
|
$
|
6,738
|
|
$
|
6,958
|
|
$
|
1,764
|
|
$
|
12,079
|
|
$
|
13,843
|
|
||||||
Asia
|
|
7,778
|
|
|
—
|
|
|
7,778
|
|
|
7,536
|
|
|
—
|
|
|
7,536
|
|
||||||
Europe
|
|
—
|
|
|
57
|
|
|
57
|
|
|
67
|
|
|
119
|
|
|
186
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total net revenues
|
$
|
7,998
|
|
$
|
6,795
|
|
$
|
14,793
|
|
$
|
9,367
|
|
$
|
12,198
|
|
$
|
21,565
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
Nine Months Ended
|
|||||||||||||||||||||||
October 2, 2021
|
September 26, 2020
|
|||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
Photonics
|
Total
|
TFE
|
Photonics
|
Total
|
|||||||||||||||||||
United States
|
$
|
2,708
|
|
$
|
22,069
|
|
$
|
24,777
|
|
$
|
2,596
|
|
$
|
35,060
|
|
$
|
37,656
|
|
||||||
Asia
|
|
16,047
|
|
|
—
|
|
|
16,047
|
|
|
31,262
|
|
|
—
|
|
|
31,262
|
|
||||||
Europe
|
|
3,850
|
|
|
173
|
|
|
4,023
|
|
|
67
|
|
|
263
|
|
|
330
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
Total net revenues
|
$
|
22,605
|
|
$
|
22,242
|
|
$
|
44,847
|
|
$
|
33,925
|
|
$
|
35,323
|
|
$
|
69,248
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended
|
Three Months Ended
|
|||||||||||||||||||||||
October 2, 2021
|
September 26, 2020
|
|||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
Photonics
|
Total
|
TFE
|
Photonics
|
Total
|
|||||||||||||||||||
Products transferred at a point in time
|
$
|
7,998
|
|
$
|
259
|
|
$
|
8,257
|
|
$
|
9,367
|
|
$
|
574
|
|
$
|
9,941
|
|
||||||
Products and services transferred over time
|
|
—
|
|
|
6,536
|
|
|
6,536
|
|
|
—
|
|
|
11,624
|
|
|
11,624
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$
|
7,998
|
|
$
|
6,795
|
|
$
|
14,793
|
|
$
|
9,367
|
|
$
|
12,198
|
|
$
|
21,565
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended
|
Nine Months Ended
|
|||||||||||||||||||||||
October 2, 2021
|
September 26, 2020
|
|||||||||||||||||||||||
(In thousands)
|
||||||||||||||||||||||||
TFE
|
Photonics
|
Total
|
TFE
|
Photonics
|
Total
|
|||||||||||||||||||
Products transferred at a point in time
|
$
|
22,605
|
|
$
|
574
|
|
$
|
23,179
|
|
$
|
33,925
|
|
$
|
1,649
|
|
$
|
35,574
|
|
||||||
Products and services transferred over time
|
|
—
|
|
|
21,668
|
|
|
21,668
|
|
|
—
|
|
|
33,674
|
|
|
33,674
|
|
||||||
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||
$
|
22,605
|
|
$
|
22,242
|
|
$
|
44,847
|
|
$
|
33,925
|
|
$
|
35,323
|
|
$
|
69,248
|
|
|||||||
|
|
|
|
|
|
|
|
|
|
|
|
October 2,
2021
|
January 2,
2021
|
Nine Months
Change
|
||||||||||
(In thousands)
|
||||||||||||
TFE:
|
||||||||||||
Contract assets:
|
||||||||||||
Accounts receivable, unbilled
|
$ | — | $ | 369 | $ | (369 | ) | |||||
|
|
|
|
|
|
|||||||
Contract liabilities:
|
||||||||||||
Deferred revenue
|
$ | 197 | $ | 482 | $ | (285 | ) | |||||
Customer advances
|
24 | 33 | (9 | ) | ||||||||
|
|
|
|
|
|
|||||||
$ | 221 | $ | 515 | $ | (294 | ) | ||||||
|
|
|
|
|
|
|||||||
Photonics:
|
||||||||||||
Contract assets:
|
||||||||||||
Accounts receivable, unbilled
|
$ | 1,493 | $ | 5,439 | $ | (3,946 | ) | |||||
Retainage
|
87 | 126 | (39 | ) | ||||||||
|
|
|
|
|
|
|||||||
$ | 1,580 | $ | 5,565 | $ | (3,985 | ) | ||||||
|
|
|
|
|
|
|||||||
Contract liabilities:
|
||||||||||||
Deferred revenue
|
$ | 550 | $ | 779 | $ | (229 | ) | |||||
|
|
|
|
|
|
3.
|
Inventories
|
October 2,
|
January 2,
|
|||||||
2021
|
2021
|
|||||||
(In thousands)
|
||||||||
Raw materials
|
$ | 11,262 | $ | 9,999 | ||||
Work-in-progress
|
6,929 | 4,832 | ||||||
Finished goods
|
4,262 | 6,858 | ||||||
|
|
|
|
|||||
$ | 22,453 | $ | 21,689 | |||||
|
|
|
|
4.
|
Equity-Based Compensation
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Equity-based compensation by type of award:
|
||||||||||||||||
Stock options
|
$ | 27 | $ | 47 | $ | 159 | $ | 411 | ||||||||
RSUs
|
673 | 495 | 1,872 | 1,311 | ||||||||||||
ESPP awards
|
185 | 316 | 841 | 464 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total equity-based compensation
|
$ | 885 | $ | 858 | $ | 2,872 | $ | 2,186 | ||||||||
|
|
|
|
|
|
|
|
Shares
|
Weighted-Average
Exercise Price
|
|||||||
Options outstanding at January 2, 2021
|
1,814,467 | $ | 6.66 | |||||
Options granted
|
— | $ | — | |||||
Options cancelled and forfeited
|
(211,042 | ) | $ | 7.47 | ||||
Options exercised
|
(73,744 | ) | $ | 5.89 | ||||
|
|
|||||||
Options outstanding at October 2, 2021
|
1,529,681 | $ | 6.57 | |||||
|
|
|||||||
Options exercisable at October 2, 2021
|
1,317,356 | $ | 6.78 |
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021 |
September 26,
2020 |
October 2,
2021 |
September 26,
2020 |
|||||||||||||
Stock Options:
|
||||||||||||||||
Weighted-average fair value of grants per share
|
$
|
—
|
|
$
|
—
|
|
$
|
—
|
|
$
|
1.82
|
|
||||
Expected volatility
|
|
—
|
|
|
—
|
|
|
—
|
|
|
46.04
|
%
|
||||
Risk-free interest rate
|
|
—
|
|
|
—
|
|
|
—
|
|
|
0.44
|
%
|
||||
Expected term of options (in years)
|
|
—
|
|
|
—
|
|
|
—
|
|
4.39
|
|
|||||
Dividend yield
|
|
—
|
|
|
—
|
|
|
—
|
|
|
None
|
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021 |
September 26,
2020 |
October 2,
2021 |
September 26,
2020 |
|||||||||||||
Stock Purchase Rights:
|
||||||||||||||||
Weighted-average fair value of grants per share
|
$
|
2.43
|
|
$
|
2.20
|
|
$
|
2.59
|
|
$
|
2.20
|
|
||||
Expected volatility
|
|
64.94
|
%
|
|
51.72
|
%
|
|
60.88
|
%
|
|
51.49
|
%
|
||||
Risk-free interest rate
|
|
0.07
|
%
|
|
0.12
|
%
|
|
0.08
|
%
|
|
0.14
|
%
|
||||
Expected term of purchase rights (in years)
|
|
0.75
|
|
|
1.26
|
|
|
0.91
|
|
|
1.24
|
|
||||
Dividend yield
|
|
None
|
|
|
None
|
|
|
None
|
|
|
None
|
|
Shares
|
Weighted-Average
Grant Date
Fair Value
|
|||||||
Non-vested
RSUs at January 2, 2021
|
901,634 | $ | 5.30 | |||||
Granted
|
590,931 | $ | 6.18 | |||||
Vested
|
(301,305 | ) | $ | 6.07 | ||||
Cancelled and forfeited
|
(82,529 | ) | $ | 4.66 | ||||
|
|
|||||||
Non-vested
RSUs at October 2, 2021
|
1,108,731 | $ | 5.60 | |||||
|
|
Nine Months Ended
|
||||
October 2, 2021
|
||||
Weighted-average fair value of grants per share
|
$ | 7.65 | ||
Expected volatility
|
56.26 | % | ||
Risk-free interest rate
|
0.15 | % | ||
Dividend yield
|
None |
Nine Months Ended
|
||||
September 26, 2020
|
||||
Weighted-average fair value of grants per share
|
$ | 3.16 | ||
Expected volatility
|
46.7 | % | ||
Risk-free interest rate
|
0.25 | % | ||
Dividend yield
|
None |
5.
|
Warranty
|
Three Months Ended
|
Nine Months Ended
|
|||||||||||||||
October 2,
2021
|
September 26,
2020
|
October 2,
2021
|
September 26,
2020
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Opening balance
|
$ | 572 | $ | 662 | $ | 480 | $ | 1,022 | ||||||||
Expenditures incurred under warranties
|
(148 | ) | (89 | ) | (564 | ) | (398 | ) | ||||||||
Accruals for product warranties issued during the reporting period
|
80 | 39 | 553 | 198 | ||||||||||||
Adjustments to previously existing warranty accruals
|
106 | (57 | ) | 141 | (267 | ) | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Closing balance
|
$ | 610 | $ | 555 | $ | 610 | $ | 555 | ||||||||
|
|
|
|
|
|
|
|
October 2,
2021
|
January 2,
2021
|
|||||||
(In thousands)
|
||||||||
Other accrued liabilities
|
$ | 542 | $ | 405 | ||||
Other long-term liabilities
|
68 | 75 | ||||||
|
|
|
|
|||||
Total warranty provision
|
$ | 610 | $ | 480 | ||||
|
|
|
|
6.
|
Guarantees
|
7.
|
Cash, Cash Equivalents and Investments
|
October 2, 2021
|
||||||||||||||||
Amortized Cost
|
Unrealized
Holding
Gains
|
Unrealized
Holding
Losses
|
Fair Value
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Cash and cash equivalents:
|
||||||||||||||||
Cash
|
$ | 28,749 | $ | — | $ | — | $ | 28,749 | ||||||||
Money market funds
|
4,447 | — | — | 4,447 | ||||||||||||
Municipal bonds
|
500 | — | — | 500 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash and cash equivalents
|
$ | 33,696 | $ | — | $ | — | $ | 33,696 | ||||||||
Short-term investments:
|
||||||||||||||||
Certificates of deposit
|
$ | 6,299 | $ | 3 | $ | — | $ | 6,302 | ||||||||
Commercial paper
|
400 | — | — | 400 | ||||||||||||
Corporate bonds and medium-term notes
|
2,919 | 1 | — | 2,920 | ||||||||||||
Municipal bonds
|
515 | — | — | 515 | ||||||||||||
U.S. treasury and agency securities
|
1,000 | — | — | 1,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments
|
$ | 11,133 | $ | 4 | $ | — | $ | 11,137 | ||||||||
Long-term investments:
|
||||||||||||||||
Asset backed securities
|
$ | 480 | $ | — | $ | — | $ | 480 | ||||||||
Certificates of deposit
|
500 | — | 1 | 499 | ||||||||||||
Corporate bonds and medium-term notes
|
2,541 | 1 | 1 | 2,541 | ||||||||||||
Municipal bonds
|
145 | — | 1 | 144 | ||||||||||||
U.S. treasury and agency securities
|
2,161 | — | — | 2,161 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total long-term investments
|
$ | 5,827 | $ | 1 | $ | 3 | $ | 5,825 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash, cash equivalents, and investments
|
$ | 50,656 | $ | 5 | $ | 3 | $ | 50,658 | ||||||||
|
|
|
|
|
|
|
|
January 2, 2021
|
||||||||||||||||
Amortized Cost
|
Unrealized
Holding Gains |
Unrealized
Holding Losses |
Fair Value
|
|||||||||||||
(In thousands)
|
||||||||||||||||
Cash and cash equivalents:
|
||||||||||||||||
Cash
|
$ | 24,729 | $ | — | $ | — | $ | 24,729 | ||||||||
Money market funds
|
3,612 | — | — | 3,612 | ||||||||||||
Certificates of deposit
|
1,000 | — | — | 1,000 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash and cash equivalents
|
$ | 29,341 | $ | — | $ | — | $ | 29,341 | ||||||||
Short-term investments:
|
||||||||||||||||
Certificates of deposit
|
$ | 6,450 | $ | 2 | $ | — | $ | 6,452 | ||||||||
Commercial paper
|
500 | — | — | 500 | ||||||||||||
Corporate bonds and medium-term notes
|
2,929 | 6 | — | 2,935 | ||||||||||||
Municipal bonds
|
400 | — | — | 400 | ||||||||||||
U.S. treasury and agency securities
|
4,527 | 25 | — | 4,552 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total short-term investments
|
$ | 14,806 | $ | 33 | $ | — | $ | 14,839 | ||||||||
Long-term investments:
|
||||||||||||||||
Certificates of deposit
|
$ | 500 | $ | — | $ | — | $ | 500 | ||||||||
Corporate bonds and medium-term notes
|
3,474 | 4 | — | 3,478 | ||||||||||||
U.S. treasury and agency securities
|
1,409 | 1 | — | 1,410 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Total long-term investments
|
$ | 5,383 | $ | 5 | $ | — | $ | 5,388 | ||||||||
|
|
|
|
|
|
|
|
|||||||||
Total cash, cash equivalents, and investments
|
$ | 49,530 | $ | 38 | $ | — | $ | 49,568 | ||||||||
|
|
|
|
|
|
|
|
October 2, 2021
|
||||||||
Amortized
Cost
|
Fair Value
|
|||||||
(In thousands)
|
||||||||
Due in one year or less
|
$ | 16,080 | $ | 16,084 | ||||
Due after one through three years
|
5,827 | 5,825 | ||||||
|
|
|
|
|||||
$ | 21,907 | $ | 21,909 | |||||
|
|
|
|
October 2, 2021
|
||||||||||||||||
In Loss Position for
Less than 12 Months
|
In Loss Position for
Greater than 12 Months
|
|||||||||||||||
Fair Value
|
Gross
Unrealized
Losses
|
Fair Value
|
Gross
Unrealized
Losses |
|||||||||||||
(In thousands)
|
||||||||||||||||
Certificates of deposit
|
$ | 499 | $ | 1 | $ | — | $ | — | ||||||||
Corporate bonds and medium-term notes
|
1,944 | 1 | — | — | ||||||||||||
Municipal bond
|
145 | 1 | — | — | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
$ | 2,588 | $ | 3 | $ | — | $ | — | |||||||||
|
|
|
|
|
|
|
|
Fair Value Measurements
at October 2, 2021
|
||||||||||||
Total
|
Level 1
|
Level 2
|
||||||||||
(In thousands)
|
||||||||||||
Recurring fair value measurements:
|
||||||||||||
Available-for-sale
|
||||||||||||
Money market funds
|
$ | 4,447 | $ | 4,447 | $ | — | ||||||
U.S. treasury and agency securities
|
3,161 | 3,161 | — | |||||||||
Asset backed securities
|
480 | — | 480 | |||||||||
Certificates of deposit
|
6,801 | — | 6,801 | |||||||||
Commercial paper
|
400 | — | 400 | |||||||||
Corporate bonds and medium-term notes
|
5,461 | — | 5,461 | |||||||||
Municipal bonds
|
1,159 | — | 1,159 | |||||||||
|
|
|
|
|
|
|||||||
Total recurring fair value measurements
|
$ | 21,909 | $ | 7,608 | $ | 14,301 | ||||||
|
|
|
|
|
|
8.
|
Derivative Instruments
|
(a) |
Other accrued liabilities
|
9.
|
Equity
|
Three months ended October 2, 2021
|
||||||||||||||||||||
Common
Stock and Additional
Paid-in
Capital |
Treasury
Stock |
Accumulated
Other Comprehensive Income |
Accumulated
Deficit |
Total
Stockholders’ Equity |
||||||||||||||||
Balance at July 3, 2021
|
$ | 196,088 | $ | (29,551 | ) | $ | 571 | $ | (75,360 | ) | $ | 91,748 | ||||||||
Common stock issued under employee plans
|
1,182 | — | — | — | 1,182 | |||||||||||||||
Shares withheld for net share settlement of RSUs
|
(13 | ) | — | — | — | (13 | ) | |||||||||||||
Equity-based compensation expense
|
885 | — | — | — | 885 | |||||||||||||||
Net loss
|
— | — | — | (4,233 | ) | (4,233 | ) | |||||||||||||
Other comprehensive loss
|
— | — | (14 | ) | — | (14 | ) | |||||||||||||
|
|
|
|
|
|
|
|
|
|
|||||||||||
Balance at October 2, 2021
|
$ | 198,142 | $ | (29,551 | ) | $ | 557 | $ | (79,593 | ) | $ | 89,555 | ||||||||
|
|
|
|
|
|
|
|
|
|
Nine months ended October 2, 2021
|
||||||||||||||||||||
Common
Stock and Additional
Paid-in
Capital |
Treasury
Stock |
Accumulated
Other Comprehensive Income |
Accumulated
Deficit |
Total
Stockholders’ Equity |
||||||||||||||||
Balance at January 2, 2021
|
$ | 193,197 | $ | (29,551 | ) | $ | 640 | $ | (62,730 | ) | $ | 101,556 | ||||||||
Common stock issued under employee plans
|
2,618 | — | — | — | 2,618 | |||||||||||||||
Shares withheld for net share settlement of RSUs
|
(545 | ) | — | — | — | (545 | ) | |||||||||||||
Equity-based compensation expense
|
2,872 | — | — | — | 2,872 | |||||||||||||||
Net loss
|
— | — | — | (16,863 | ) | (16,863 | ) | |||||||||||||
Other comprehensive loss
|
— | — | (83 | ) | — | (83 | ) | |||||||||||||